Remdesivir inhibits endothelial activation and atherosclerosis by coupling TAL1 to TRAF6
Abstract Background Atherosclerosis is characterized by complex pathological processes, including endothelial dysfunction and inflammation. The underlying pathogenic mechanisms have been well elucidated; however, effective treatments are yet to be validated. Our study explored the novel application...
Saved in:
| Main Authors: | Hanning Zhang, Ruru Li, Qianqian Huo, Li Li, Min Li, Shunxin Hu, Changjie Ren, Zongyin Wu, Chenghu Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Journal of Translational Medicine |
| Online Access: | https://doi.org/10.1186/s12967-025-06673-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atorvastatin Attenuates Endothelial Cell Injury in Atherosclerosis Through Inhibiting ACSL4-Mediated Ferroptosis
by: Huilian Tan, et al.
Published: (2024-01-01) -
Different Activation of TRAF4 and TRAF6 in Inflammatory Bowel Disease
by: Jun Shen, et al.
Published: (2013-01-01) -
SPTBN1 overexpression ameliorates atherosclerosis by inhibiting oxidative stress and inflammation via regulating the TRIM37/TRAF2/NF-κB pathway
by: Senyan Wu, et al.
Published: (2025-08-01) -
TRAF7 knockdown induces cellular senescence and synergizes with lomustine to inhibit glioma progression and recurrence
by: Yu Chen, et al.
Published: (2025-04-01) -
TRAF3IP3 Induces ER Stress‐Mediated Apoptosis with Protective Autophagy to Inhibit Lung Adenocarcinoma Proliferation
by: Guang Zhao, et al.
Published: (2025-05-01)